RNAC – cartesian therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit [Yahoo! Finance]
Cartesian Therapeutics to Present Updated Data from Phase 2b Trial of Descartes-08 in Patients with Myasthenia Gravis at the 2nd Annual Cell Therapy for Autoimmune Disease Summit
Timothy Springer Bought 4.9% More Shares In Cartesian Therapeutics [Yahoo! Finance]
Yale University's Strategic Bet on Cartesian Therapeutics Skyrockets in Q3 2024 [Yahoo! Finance]
Cartesian Therapeutics, Inc. (NASDAQ: RNAC) had its price target lowered by analysts at HC Wainwright from $45.00 to $41.00. They now have a "buy" rating on the stock.
Form 4 Cartesian Therapeutics, For: Nov 19 Filed by: Kurtoglu Metin
Form 4 Cartesian Therapeutics, For: Nov 19 Filed by: Singer Michael
Form 4 Cartesian Therapeutics, For: Nov 20 Filed by: Jewell Christopher M
Form 144 Cartesian Therapeutics, Filed by: Kurtoglu Metin
Form 144 Cartesian Therapeutics, Filed by: Kurtoglu Metin
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.